The global urine output monitoring systems market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.09% during the forecast period from 2024 to 2030. The demand for urine output monitoring systems is primarily being boosted by the growing prevalence of kidney disorders globally, and the higher emphasis of healthcare providers towards continuous monitoring and efficient management of kidney disorders, are some factors anticipated to fuel the demand for urine output monitoring systems during the forecast period from 2024-2030.
According to statistics by Kidney Care UK (2021), around 3.5 million people in the United Kingdom have Chronic Kidney Disease (CKD), in the UK in 2021. As per Eurostat (2021), every day 20 people in the United Kingdom develop kidney failure on average. The source further stated that around 1,000 children were suffering from CKD in the United Kingdom in the year 2020. According to the Europe PMC 2020, chronic kidney disease affected approximately 3 million people in France, in the year 2020.
As per the Kidney Health Australia 2022, about 1 in 10 Australian adults have signs of chronic kidney disease. According to the Australian Institute of Health and Welfare (2022), it was estimated that 1.7 million Australians were living with early signs of kidney disease in 2021, but many Australians were unaware due to the initially asymptomatic and progressive nature of chronic kidney disease.
Urine output measurement is regarded as a crucial indicator for tracking the health of the patient's kidneys. Thus, with an increase in the number of people with kidney disorders, there will be an increased demand for fluid management and the monitoring of kidney disorders through urine output monitoring systems.
The increasing number of risk factors for kidney diseases such as diabetes, hypertension, and old age among others is further going to positively impact the growth of the urine monitoring systems market. For instance, the data published by the International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021. Also, as per the Japan Association of Chronic Kidney Disease Initiatives, 2019, in Japan, the prevalence of end-stage renal disorder (ESRD) is increasing and was more than 2,000 per million population, in the year 2019. More than 40% of incident ESRD is due to diabetes mellitus (DM). Thus, the increasing prevalence of diabetes could also affect the market of urine output monitoring systems market.
However, challenges such as inaccuracy, discomfort, and others associated with urine output monitoring systems and limited access to kidney care facilities, particularly in low-income countries may restrict the growth of the overall urine output monitoring systems market.
In the product type segment of the Urine Output Monitoring Systems market, the automated urine output monitoring systems category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the various advantages associated with automated urine output monitoring systems in comparison to manual systems.
Automated urine output monitoring systems can be used for bedside monitoring of patients with kidney disorders on a routine basis to get significantly more accurate urine output measurements. In addition to lowering workload and human error, automated systems can send alerts and cautions when certain values deviate from a predetermined range.
For example, Sensica™ Urine Output System by BD is an automated urine output monitoring system that allows for bedside monitoring of any patient. The system continuously monitors urine output and core bladder temperature and can automatically transmit data into the patient's electronic medical record (EMR).
Further, according to the study investigations, an automated system monitors urine output far more effectively than manual techniques. The accuracy provided by manual monitoring of urine output may be insufficient to detect kidney diseases like acute kidney injury (AKI) and others in some patients as in manual systems, recordings are often missed.
Therefore, owing to the above-mentioned factors, the automated urine output monitoring systems category is expected to register significant growth, thereby driving the growth of the overall urine output monitoring systems market during the forecast period.
As per the Centers for Disease Control and Prevention (CDC) 2023, about 35.5 million people, which makes more than 1 in 7 US adults were estimated to have chronic kidney disease (CKD) in 2021. As per the same source as many as 9 in 10 adults in the US with CKD do not know they have it and about 1 in 3 adults with severe CKD do not know they have CKD.
Another prominent factor supporting the growth of the regional urine output monitoring systems market is the rising prevalence of diabetes which increases the risk for kidney disorders, in the United States. For instance, as per the Centers for Disease Control and Prevention (CDC) 2021, around 28.7 million people in the US had diabetes in the year 2019. Moreover, as per the Centers for Disease Control and Prevention 2022 data, around 96 million people had prediabetic conditions in the year 2019 in the US.
Thus, the above-mentioned factors are likely to propel the growth of the urine output monitoring systems market in the region during the forecast period from 2024-2030.
This product will be delivered within 2 business days.
Urine Output Monitoring Systems Market Dynamics:
The latest data published by the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022.According to statistics by Kidney Care UK (2021), around 3.5 million people in the United Kingdom have Chronic Kidney Disease (CKD), in the UK in 2021. As per Eurostat (2021), every day 20 people in the United Kingdom develop kidney failure on average. The source further stated that around 1,000 children were suffering from CKD in the United Kingdom in the year 2020. According to the Europe PMC 2020, chronic kidney disease affected approximately 3 million people in France, in the year 2020.
As per the Kidney Health Australia 2022, about 1 in 10 Australian adults have signs of chronic kidney disease. According to the Australian Institute of Health and Welfare (2022), it was estimated that 1.7 million Australians were living with early signs of kidney disease in 2021, but many Australians were unaware due to the initially asymptomatic and progressive nature of chronic kidney disease.
Urine output measurement is regarded as a crucial indicator for tracking the health of the patient's kidneys. Thus, with an increase in the number of people with kidney disorders, there will be an increased demand for fluid management and the monitoring of kidney disorders through urine output monitoring systems.
The increasing number of risk factors for kidney diseases such as diabetes, hypertension, and old age among others is further going to positively impact the growth of the urine monitoring systems market. For instance, the data published by the International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021. Also, as per the Japan Association of Chronic Kidney Disease Initiatives, 2019, in Japan, the prevalence of end-stage renal disorder (ESRD) is increasing and was more than 2,000 per million population, in the year 2019. More than 40% of incident ESRD is due to diabetes mellitus (DM). Thus, the increasing prevalence of diabetes could also affect the market of urine output monitoring systems market.
However, challenges such as inaccuracy, discomfort, and others associated with urine output monitoring systems and limited access to kidney care facilities, particularly in low-income countries may restrict the growth of the overall urine output monitoring systems market.
Urine Output Monitoring Systems Market Segment Analysis:
Urine Output Monitoring Systems Market by Product Type (Manual Urine Output Monitoring Systems and Automated Urine Output Monitoring Systems), Usage (Disposable and Reusable), End-User (Hospital, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)In the product type segment of the Urine Output Monitoring Systems market, the automated urine output monitoring systems category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the various advantages associated with automated urine output monitoring systems in comparison to manual systems.
Automated urine output monitoring systems can be used for bedside monitoring of patients with kidney disorders on a routine basis to get significantly more accurate urine output measurements. In addition to lowering workload and human error, automated systems can send alerts and cautions when certain values deviate from a predetermined range.
For example, Sensica™ Urine Output System by BD is an automated urine output monitoring system that allows for bedside monitoring of any patient. The system continuously monitors urine output and core bladder temperature and can automatically transmit data into the patient's electronic medical record (EMR).
Further, according to the study investigations, an automated system monitors urine output far more effectively than manual techniques. The accuracy provided by manual monitoring of urine output may be insufficient to detect kidney diseases like acute kidney injury (AKI) and others in some patients as in manual systems, recordings are often missed.
Therefore, owing to the above-mentioned factors, the automated urine output monitoring systems category is expected to register significant growth, thereby driving the growth of the overall urine output monitoring systems market during the forecast period.
North America is expected to dominate the overall Urine Output Monitoring Systems Market:
Among all the regions, North America is estimated to account for the largest share of the urine output monitoring systems market in the year 2023. Owing to the significance of key growth factors such as the rise in number of people with kidney disorders, higher health awareness, increasing disposable incomes, presence of key players, increasing product development activities, and others, the market for urine output monitoring systems is expected to witness prosperity in the region during the forecast period.As per the Centers for Disease Control and Prevention (CDC) 2023, about 35.5 million people, which makes more than 1 in 7 US adults were estimated to have chronic kidney disease (CKD) in 2021. As per the same source as many as 9 in 10 adults in the US with CKD do not know they have it and about 1 in 3 adults with severe CKD do not know they have CKD.
Another prominent factor supporting the growth of the regional urine output monitoring systems market is the rising prevalence of diabetes which increases the risk for kidney disorders, in the United States. For instance, as per the Centers for Disease Control and Prevention (CDC) 2021, around 28.7 million people in the US had diabetes in the year 2019. Moreover, as per the Centers for Disease Control and Prevention 2022 data, around 96 million people had prediabetic conditions in the year 2019 in the US.
Thus, the above-mentioned factors are likely to propel the growth of the urine output monitoring systems market in the region during the forecast period from 2024-2030.
Urine Output Monitoring Systems Market Key Players:
Some of the key market players operating in the Urine Output Monitoring Systems market include BD, Potrero Medical Inc., 3i Group plc, Serenno Medical, RenalSense Ltd., FIZE Medical, and Others.Recent Developmental Activities in the Urine Output Monitoring Systems Market:
- In February 2020, Serenno Medical introduced the Sentinel device for continuous automatic monitoring and detection of kidney damage in hospitalized patients.
- In August 2019, RenalSense received the CE Mark for its Clarity RMS, a critical care monitoring platform that constantly measures a patient’s urine flow.
Key Takeaways from the Urine Output Monitoring Systems Market Report Study
- Market size analysis for current urine output monitoring systems market size (2023), and market forecast for 6 years (2024-2030)
- Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
- Key companies dominating the global urine output monitoring systems market.
- Various opportunities available for the other competitors in the urine output monitoring systems market space.
- What are the top-performing segments in 2023? How these segments will perform in 2030?
- Which are the top-performing regions and countries in the current urine output monitoring systems market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for urine output monitoring systems market growth in the coming future?
Target Audience who can be benefited from this Urine Output Monitoring Systems Market Report Study
- Urine Output Monitoring Systems product providers
- Research organizations and consulting companies
- Urine Output Monitoring Systems -related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Urine Output Monitoring Systems
- Various End-users who want to know more about the urine output monitoring systems market and the latest developments in the urine output monitoring systems market.
Frequently Asked Questions for the Urine Output Monitoring Systems Market:
1. What are urine output monitoring systems?
Urine Output Monitoring Systems are used for monitoring urine output, including both volume and flow rate, either manually or automatically.2. What is the market for global urine output monitoring systems?
The global urine output monitoring systems market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.09% during the forecast period from 2024 to 2030.3. What are the drivers for the global urine output monitoring systems market?
The demand for urine output monitoring systems is primarily being boosted by the growing prevalence of kidney disorders globally, and the higher emphasis of healthcare providers towards continuous monitoring and efficient management of kidney disorders, are some factors anticipated to fuel the demand for urine output monitoring systems during the forecast period from 2024-2030.4. Who are the key players operating in the global urine output monitoring systems market?
Some of the key market players operating in the urine output monitoring systems market include BD, Potrero Medical Inc., 3i Group plc, Serenno Medical, RenalSense Ltd., FIZE Medical, and Others.5. Which region has the highest share in the urine output monitoring systems market?
North America is expected to dominate the overall urine output monitoring systems market during the forecast period from 2024-2030. Owing to factors such as a surge in cases of kidney disorders, increasing burden of diabetes, higher health awareness, increasing disposable incomes, the presence of key players, increasing product development activities, and others, the North American urine output monitoring systems market is expected to grow in the coming years.This product will be delivered within 2 business days.
Table of Contents
1. Urine Output Monitoring Systems Market Report Introduction8. KOL Views9. Project Approach10. Publisher Capabilities11. About the Publisher12. Disclaimer
2. Urine Output Monitoring Systems Market Executive Summary
3. Regulatory Analysis
4. Urine Output Monitoring Systems Market Key Factors Analysis
5. Urine Output Monitoring Systems Market Porter’s Five Forces Analysis
6. Urine Output Monitoring Systems Market Layout
7. Urine Output Monitoring Systems Market Company and Product Profiles
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- Potrero Medical Inc.
- 3i Group plc
- Serenno Medical
- RenalSense Ltd.
- FIZE Medical